Israel's Redhill Biopharma signs deal for potential COVID-19 treatment
Redhill did not disclose terms of the deal or the name of the manufacturing companies.
Vials of investigational coronavirus disease (COVID-19) treatment drug are capped at a facility.(photo credit: GILEAD SCIENCES INC/HANDOUT VIA REUTERS)ByREUTERS
